Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
Test your neurology knowledge with NeurologyLive®'s weekly quiz featuring questions on a variety of clinical and neurological history topics. This week's theme is movement.
Read Full NewsFor children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.
Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.
Interpret findings with caution, but AI-based radiomics may help curb unnecessary procedures.
The CQC's 2025 survey of 58,000 patients found rising satisfaction overall, but discharge planning remains an area of difficulty.
For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.
Sulfide overproduction in the gut can alter small bowel gene expression more than bacterial or methanogen overgrowth does, affecting mitochondrial function, redox balance, and immune signaling.
Patients referred via a specialized screening clinic that expedites rheumatoid arthritis diagnosis have lower functional disability than those referred via standard referral pathways.
1.
Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC
2.
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
3.
Including Bereavement in the Care Continuum.
4.
AVD Chemo Regimen Shows Promise in Older Patients With HL
5.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
1.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
2.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Therapies Using Combination Radiopharmaceutical Platforms for Sequential Tumor Targeting
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge